Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer

針對症狀 Pancreatic Cancer
臨床試驗編號 NCT00965718
臨床階段 Phase II
臨床試驗位址 Yonsei Medical Center
目前研究進度 This study has been completed.
試驗開始日期 August 24, 2009
試驗開始日期 March 11, 2011
臨床目的 Phase 2 Clinical trial to Evaluate the efficacy and safety of activated T-lymphocyte ("Immuncell-LC") cell therapy in Gemcitabine refractory advanced pancreatic cancer
http://www.clinicaltrial.gov/ct2/show/NCT00965718?term=innocell&rank=3